# Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.

> **NCT04930679** · PHASE1 · COMPLETED · sponsor: **Centre of Clinical Pharmacology, Hanoi Medical University** · enrollment: 14 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Andiabet

## Key facts

- **NCT ID:** NCT04930679
- **Lead sponsor:** Centre of Clinical Pharmacology, Hanoi Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-11-24
- **Primary completion:** 2019-02-22
- **Final completion:** 2019-02-22
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2021-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04930679

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04930679, "Evaluating Safety of Andiabet on Diabetes Mellitus Type II Patients, Phase I CT.". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04930679. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*